Alterity Therapeutics Ltd. (AU:ATH) has released an update.
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Alterity Therapeutics has appointed Abby Macnish Niven as the new Company Secretary following her recent role as Chief Financial Officer. With a strong background in finance and governance, Ms. Macnish Niven brings extensive expertise to the company as it pursues advancements in treating neurodegenerative diseases. This leadership change signals a strategic move for Alterity as it continues its focus on innovative drug development.
For further insights into AU:ATH stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Boeing (NYSE:BA) Layoffs Expand, Start Hitting Multiple Factories
- Microsoft’s (NASDAQ:MSFT) New Computer is Exclusively a Cloud Machine
- Walmart (NYSE:WMT) Warns About Tariff-Driven Price Hikes
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
